"Hematinics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.
| Descriptor ID |
D006397
|
| MeSH Number(s) |
D27.505.954.502.543
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematinics".
Below are MeSH descriptors whose meaning is more specific than "Hematinics".
This graph shows the total number of publications written about "Hematinics" by people in this website by year, and whether "Hematinics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2017 | 9 | 8 | 17 |
| 2018 | 4 | 3 | 7 |
| 2019 | 2 | 2 | 4 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematinics" by people in Profiles.
-
Revisiting the treatment of anemia in the setting of chronic kidney disease, hematologic malignancies, and cancer: perspectives with opinion and commentary. Expert Rev Hematol. 2020 11; 13(11):1175-1188.
-
Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report. A A Pract. 2020 Jul; 14(9):e01287.
-
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19. Am J Kidney Dis. 2020 09; 76(3):303-305.
-
Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality. Med Hypotheses. 2020 Jul; 140:109760.
-
Cost-minimization analysis between intravenous iron sucrose and iron sucrose similar in hemodialysis patients. Expert Rev Pharmacoecon Outcomes Res. 2020 Jun; 20(3):281-287.
-
Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial. J Cardiovasc Med (Hagerstown). 2019 Apr; 20(4):223-225.
-
Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis. Can J Anaesth. 2019 06; 66(6):716-731.
-
Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. JAMA. 2019 Mar 12; 321(10):983-997.
-
Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study. ESC Heart Fail. 2018 12; 5(6):1052-1059.
-
T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF. Clin Res Cardiol. 2019 Feb; 108(2):133-141.